Get Our FREE Newsletter

Sign Up

This Bearish Biotech ETF Is up 16% in the Past Month

Spread the love

The biotech sector was one of the darlings amid the vaccine rally in 2020, but there’s since been some bearishness, which is benefiting the Direxion Daily S&P Biotech Bear 3X Shares (LABD). LABD climbed 16% the past month, giving bearish biotech traders something to cheer about. Of course, it helps to have leverage with LABD […] Read more at ETFtrends.com.

This post was originally published on this site